DBN1 and Alzheimer disease: Drebrin (DBN) regulates cytoskeletal functions during neuronal development, and is thought to contribute to structural and functional synaptic changes associated with ageing and Alzheimer’s disease (AD) (Kreis et al., 2019; Shirao et al., 2017; Sonego et al., 2025).